Navigation Links
PreViser and Oral Health Innovations Ltd Form UK Partnership to Provide Oral Health Scoring and Risk Analysis
Date:5/20/2008

MOUNT VERNON, Wash., May 20 /PRNewswire/ -- PreViser Corporation (http://www.previser.com), a Washington State-based provider of patented oral disease and risk assessment technology to the dental profession, announced today the finalization of a licensing agreement with Oral Health Innovations (OHI) Ltd (http://www.previser.co.uk) of Birmingham, England to market PreViser technology to dentists within the United Kingdom and the Republic of Ireland.

OHI Ltd is a joint venture with the University of Birmingham. Following a successful pilot, OHI will launch PreViser at a Denplan-sponsored seminar for its Excel accredited practitioners in June 2008. Discussions are also underway with a number of Primary Care Trusts on how the technology can be used as a best practice tool within National Health Service (NHS) dentistry.

Iain Chapple, Professor of Periodontology and Consultant in Restorative Dentistry, who runs an NHS referral center serving approximately six million patients, acts as adviser to OHI Ltd. Prof. Chapple commented, "PreViser is unique in its web-based approach to risk and disease scoring and has a scientific evidence base behind its efficacy. However, one of its biggest benefits is the immediate and personalized biofeedback it offers to patients. We all know that successful periodontal therapy is founded on patient education and compliance with home care regimes. PreViser is a most innovative tool that motivates patients to take personal responsibility for their own oral health.

"In addition to the obvious patient and practitioner benefits, PreViser allows oral healthcare funders to focus their resources towards those that need it most and provides a platform from which to deliver truly preventative oral care in a cost effective manner.

"As a teacher, it is exciting to be able to utilize the system, which is provided free of charge to Dental Education establishments for educational purposes. The interactive nature of the platform is something dental students actively engage in and learn from. I would encourage every dental school to take advantage of this technology."

PreViser Corporation provides web-enabled diagnostic decision support tools for dentists and dental hygienists. The PreViser Oral Health Information Suite(TM) enables quick, accurate, reproducible and objective diagnosis and analysis of oral disease risk in an easy-to-understand format for the professional and the patient.

A percentage of profits of OHI Ltd go to the Oral & Dental Research Trust of the UK and a research fellowship at the University of Birmingham.

*(LOGO 72dpi: Send2Press.com/mediaboom/08-0520-PreViser_72dpi.jpg)

For further information contact:

Oral Health Innovations Ltd: Liz Chapple, info@previser.co.uk

PreViser Corporation: Carl Loeb, 360-941-4715, info@previser.com

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE PreViser Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Eutilex Co. Ltd. today announced that ... Series A financing. This financing round included participation from ... SNU Bio Angel. This new funding brings the total ... $27.7M) since its founding in 2015. ... and commercialization of its immuno-oncology programs, expand its R&D ...
(Date:12/7/2016)... ... December 07, 2016 , ... A new ... the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not yet ... population and timing of blood sampling may improve the value of a blood-based ...
(Date:12/7/2016)... CALGARY , Dec. 7, 2016 /PRNewswire/ - Zenith Capital Corp. ... update that will be presented at the Company,s Annual and ... Meeting of Shareholders will take place on Thursday, December 15, ... Ross Glenn Hall (Room EC1040), 4825 Mount Royal Gate ... am (MST). A notice of meeting and management information circular, ...
(Date:12/7/2016)... 7, 2016  Vyriad Inc. announced today the appointment ... Board of Directors. "We are delighted to ... business and develop our oncolytic viruses as the next ... Stephen Russell , MD, PhD, CEO of Vyriad. "Al ... vision and passion for making a difference for cancer ...
Breaking Biology Technology:
(Date:11/24/2016)... Nov. 23, 2016 Cercacor today introduced Ember ... their trainers non-invasively measure hemoglobin, Oxygen Content, ... and Respiration Rate in approximately 30 seconds. Smaller than ... and immediate access to key data about their bodies ... training regimen. Hemoglobin carries oxygen to ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):